Drawing for EVANZYS

USPTO serial 79442735

EVANZYS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GEARHART, DAVID JAMES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with EVANZYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly I. Boesche

Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard125 South Wacker Drive, Suite 2050Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in industry and science, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations for research laboratory use; diagnostic preparations used in science, other than for medical or veterinary purposesACTIVE—
005Chemico-pharmaceutical preparations, namely, diagnostic agents, preparations and substances for medical use; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; diagnostic preparations for veterinary purposes; biological preparations, namely, diagnostic agents, preparations and substances for medical purposes; biological preparations, namely, diagnostic agents, preparations and substances for veterinary purposes; chemical preparations, namely, diagnostic agents, preparations and substances for medical purposes; chemical preparations, namely, namely diagnostic agents, preparations and substances for pharmaceutical purposes; chemical preparations, namely, diagnostic agents, preparations and substances for veterinary purposes; chemical reagents for medical or veterinary purposes; none of the afore mentioned goods being goods for therapeutic use in general and antibacterial use in particularACTIVE—
009Computer programs, downloadable for managing medical and laboratory testing, diagnostics, and experimentation; computer programs, recorded for managing medical and laboratory testing, diagnostics, and experimentation; computer software applications, downloadable for managing medical and laboratory testing, diagnostics, and experimentation; computer software platforms, recorded or downloadable for managing medical and laboratory testing, diagnostics, and experimentation; computer software, recorded for managing medical and laboratory testing, diagnostics, and experimentation; diagnostic apparatus for research laboratory use for detecting pathogens, microorganisms, DNA, RNA and Proteins; diagnostic apparatus, not for medical purposes for detecting pathogens, microorganisms, DNA, DNA and proteins; interfaces for computers; laboratory robots; material testing instruments and machines for detecting pathogens or microorganisms, DNA, RNA and proteins; test tubes; testing apparatus not for medical purposes for detecting pathogens, microorganisms, DNA, RNA and proteinsACTIVE—
010Apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for testing proteins, DNA, RNA; diagnostic apparatus for medical purposes used in medical laboratories for testing proteins, DNA and RNA; medical apparatus and instruments for testing proteins, DNA and RNA; surgical apparatus and instruments; testing apparatus for medical purposes for testing proteins, DNA and RNA; analysers for bacterial identification for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2026GPNXNOTIFICATION PROCESSED BY IB—
Aug 26, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 12, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2026RFNTREFUSAL PROCESSED BY IB—
May 22, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 22, 2026RFRRREFUSAL PROCESSED BY MPU—
Apr 2, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2026DOCKASSIGNED TO EXAMINER—
Feb 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 5, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance